Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Tirzepatide (Mounjaro) Tirzepatide is a dual agonist that targets both GIP and GLP-1 receptors
The approval process typically involves working closely with your healthcare provider to meet the insurance companys coverage criteria
This supports the appetite-control benefits of GLP-1 medication
Available through Klinic in Aurora, Illinois, this groundbreaking tirzepatide treatment offers a comprehensive approach to weight management that targets key hormones responsible for appetite and blood sugar regulation
US$ 20.61
US$ 27.95
US$ 22.86
US$ 20.49
